Novartis Oncology Auditor Salaries in Newark, NJ | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Auditor Salaries in Newark, NJ

The average Novartis Oncology Auditor in Newark, NJ earns an estimated $73,545 annually. Novartis Oncology's Auditor compensation is $10,850 less than the US average for a Auditor.

In Newark, NJ, The Finance Department at Novartis Oncology earns $13,966 more on average than the Operations Department.

Last updated 3 years ago.

$27k
$41k
$57k
$73k
$282k
$340k
$450k
$73,545
Average Compensation
$73,545
avg. base

Auditor Salaries at Novartis Oncology

In Newark, NJ, Auditors earn $4,186 more than Accountants, and $10,164 less than Financial Analysts.

Accounting Manager
$119k*
Business Analyst
$102k*
Senior Accountant
$94k*
Financial Analyst
$84k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Newark, NJ, The Finance Department averages $13,966 more than the Operations Department, and $22,265 less than the HR Department

HR
$107,269 Avg. total comp.
+$22k
Finance
$85,004 Avg. total comp.
Operations
$71,038 Avg. total comp.
-$14k

Auditor Compensation by Gender (All Companies)

The average female Auditor at companies similar size to Novartis Oncology reported making $88,019, while the average male Auditor at similar sized companies reported making $86,640.

Auditor Compensation by Ethnicity (All Companies)

The average Hispanic or Latino Auditor at companies similar size to Novartis Oncology reported making $111,857, while the average African American/Black Auditor at similar sized companies reported making $67,169.

How Auditors at Novartis Oncology Rate Their Compensation

The majority of Auditors at Novartis Oncology believe they're not compensated fairly. 100% of Auditors at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company